Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 6 de 6
1.
BMC Med Res Methodol ; 24(1): 117, 2024 May 20.
Article En | MEDLINE | ID: mdl-38769533

BACKGROUND: Although randomized trials and systematic reviews provide the best evidence to guide medical practice, many permanent neonatal diabetes mellitus (PNDM) studies have been published as case reports. However, the quality of these studies has not been assessed. The purpose of this study was to assess the extent to which the current case reports for PNDM comply with the Case Report (CARE) guidelines and to explore variables associated with the reporting. METHOD: Six English and four Chinese databases were searched from their inception to December 2022 for PNDM case reports. The 23 items CARE checklist was used to measure reporting quality. Primary outcome was the adherence rate of each CARE item and second outcome was total reporting score for each included PNDM case report. Linear and logistic regression analyses were used to examine the connection between five pre-specified predictor variables and the reporting quality. The predictor variables were impact factor of the published journal (<3.4 vs. ≥3.4, categorized according to the median), funding (yes vs. no), language (English vs. other language), published journal type (general vs. special) and year of publication (>2013 vs. ≤ 2013). RESULT: In total, 105 PNDM case reports were included in this study. None of the 105 PNDM case reports fulfilled all 23 items of the CARE checklist. The response rate of 11 items were under 50%, including prognostic characteristics presentation (0%), patient perspective interpretation (0%), diagnostic challenges statement (2.9%), clinical course summary (21.0%), diagnostic reasoning statement (22.9%), title identification (24.8%), case presentation (33.3%), disease history description (34.3%), strengths and limitations explanation (41.0%), informed consent statement (45.7%), and lesson elucidation (47.6%). This study identified that the PNDM case reports published in higher impact factor journals were statistically associated with a higher reporting quality. CONCLUSION: The reporting of case reports for PNDM is generally poor. As a result, this information may be misleading to providers, and the clinical applications may be detrimental to patient care. To improve reporting quality, journals should encourage strict adherence to the CARE guidelines.


Diabetes Mellitus , Humans , Cross-Sectional Studies , Diabetes Mellitus/diagnosis , Infant, Newborn , Checklist , Research Report/standards , Female , Guideline Adherence/statistics & numerical data , Male , Research Design/standards , Journal Impact Factor
3.
Cell Death Dis ; 13(2): 187, 2022 02 25.
Article En | MEDLINE | ID: mdl-35217636

Integrative expression Quantitative Trait Loci (eQTL) analysis found that rs8180040 was significantly associated with Coiled-coil domain containing 12 (CCDC12) in colon adenocarcinoma (COAD) patients. Immunohistochemical staining and western blotting confirmed CCDC12 was highly expressed in COAD tissues, which was consistent with RNA-Seq data from the TCGA database. Knockdown of CCDC12 could significantly reduce proliferation, migration, invasion, and tumorigenicity of colon cancer cells, while exogenous overexpression of CCDC12 had the opposite effect. Four plex Isobaric Tags for Relative and Absolute Quantitation assays were performed to determine its function and potential regulatory mechanism and demonstrated that overexpression of CCDC12 would change proteins on the adherens junction pathway. Overexpressed Snail and knocked down CCDC12 subsequently in SW480 cells, and we found that overexpression of Snail did not significantly change CCDC12 levels in SW480 cells, while knockdown of CCDC12 reduced that of Snail. CCDC12 plays a significant role in tumorigenesis, development, and invasion of COAD and may affect the epithelial to mesenchymal transformation process of colon cancer cells by regulating the Snail pathway.


Colonic Neoplasms , Pulmonary Disease, Chronic Obstructive , Cell Line, Tumor , Cell Movement/genetics , Cell Proliferation/genetics , Colonic Neoplasms/metabolism , Epithelial-Mesenchymal Transition/genetics , Gene Expression Regulation, Neoplastic , Humans
4.
J Cancer Res Clin Oncol ; 147(9): 2709-2719, 2021 Sep.
Article En | MEDLINE | ID: mdl-33606093

PURPOSE: Protective loop ileostomy is an effective diversion measure often used to reduce the risk of anastomotic leakage. The purpose of the present study was to evaluate the surgical outcomes of the one-stitch method (OM) of protective loop ileostomy in laparoscopic low anterior resection for BMI obesity patients with rectal cancer compared with the traditional method (TM). METHODS: The patients diagnosed as rectal adenocarcinoma cases by preoperative pathology were included in this retrospective study. The subjects underwent protective loop ileostomy in laparoscopic low anterior resection from January 2016 to June 2019 in the Shandong Provincial Hospital affiliated to Shandong University. The data of loop ileostomy and stoma closure operation were retrieved from the medical cases system of the hospital. RESULTS: 242 patients were included in the present study. In the BMI obese cohort, the OM group showed a shorter operative time both in the loop ileostomy (232.5 vs. 250.0 min, p = 0.04) and stoma closure operation (102.5 vs. 115.0 min, p = 0.001) and a lower peristomal adhesion extent (p = 0.02) and a shorter median postoperative stay (6 vs. 7 days, p = 0.03) during stoma closure operation than that of the TM group. In the TM group, obese cases showed a higher operative time of stoma closure operation (115.0 vs. 95.0, p < 0.001), a higher parastomal hernia rate (p = 0.04), a higher peristomal adhesion extent (p = 0.005) and a longer postoperative stay of stoma closure operation (p = 0.02) compared with the non-obese cases, while in the OM group, no significant differences were observed between the obese and non-obese cases in terms of the above-mentioned factors. CONCLUSIONS: The OM exhibited more advantages than TM, notably in BMI obesity patients.


Adenocarcinoma/surgery , Body Mass Index , Ileostomy/methods , Laparoscopy/methods , Length of Stay/statistics & numerical data , Obesity/physiopathology , Rectal Neoplasms/surgery , Adenocarcinoma/pathology , Female , Follow-Up Studies , Humans , Male , Middle Aged , Prognosis , Rectal Neoplasms/pathology , Retrospective Studies
5.
Int J Surg ; 80: 117-123, 2020 Aug.
Article En | MEDLINE | ID: mdl-32650118

BACKGROUND: Protective loop ileostomy is widely performed during rectal resection surgery. The study aimed to introduce the one-stitch method (OM) of protective loop ileostomy in laparoscopic low anterior resection and compare this new method with the traditional method (TM). MATERIALS AND METHODS: A retrospective analysis was conducted on 109 patients with pathologically diagnosed adenocarcinoma of the rectum from January 2017 to December 2018 in the study centre, and the intraoperative details and postoperative outcomes of the two groups were measured. RESULTS: A total of 95 patients were included: 54 underwent protective loop ileostomy with the TM, while 41 underwent surgery utilizing the OM. Univariate analysis demonstrated that the operative times of resection and closure were significantly shorter (resection, 200.0 vs. 227.5 min, P = 0.028; closure, 70.0 vs. 92.5 min, P = 0.018) and the peristomal adhesions during closure were milder (P = 0.007) in the OM group than in the TM group. The postoperative complications were similar in both groups. In multivariate analysis, the OM (OR 0.352, 95% CI = 0.155-0.799, P = 0.013) was a significant factor influencing the operative time of resection. The peristomal adhesion extent was the only independent risk factor for the stoma closure time (mild, OR 0.036, 95% CI = 0.010-0.129, P < 0.001; moderate, OR 0.128, 95% CI = 0.033-0.494, P = 0.003). No significant predictive factor of peristomal adhesion extent was identified in multivariable analysis. CONCLUSION: The OM of protective loop ileostomy in laparoscopic low anterior resection was time-saving, simple and easy to popularize and did not lead to more postoperative complications than the TM.


Adenocarcinoma/surgery , Ileostomy/methods , Laparoscopy/methods , Proctectomy/methods , Rectal Neoplasms/surgery , Adult , Aged , Female , Humans , Male , Middle Aged , Operative Time , Postoperative Complications/etiology , Rectum/pathology , Rectum/surgery , Retrospective Studies , Risk Factors , Tissue Adhesions/etiology , Treatment Outcome
6.
Biomed Pharmacother ; 99: 96-100, 2018 Mar.
Article En | MEDLINE | ID: mdl-29329036

OBJECTIVE: Immunotherapy is important to improve the survival of children with acute lymphoblastic leukemia (ALL). This study aimed to assess the effects of crocin on the proliferation and function of T cells isolated from children with ALL. METHODS: The mononuclear cells were isolated from peripheral blood of children with ALL and then treated with different final concentrations of crocin. The levels of different cytokines secreted by T cells and the ratio of CD4 and CD8 were measured. Tail DNA% (TDNA), Tail moment (TM), Tail length (TL) and sister chromatid exchange (SCE) were detected to assess DNA damage of T cells. RESULTS: Crocin significantly promoted T cell proliferation and the secretion of IL-2 and IL-4 in a concentration dependent manner. In addition, crocin increased CD4/CD8 ratio of T subset. Crocin itself caused no significant damage to T cells but reduced DNA damage in T cells treated with Ara-C. CONCLUSIONS: Crocin could improve the proliferation and cytotoxic function of T cells, and reduce DNA damage caused by Ara-C.


Apoptosis/drug effects , Carotenoids/therapeutic use , Cytotoxicity, Immunologic , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma/immunology , T-Lymphocytes/pathology , CD4-CD8 Ratio , Carotenoids/pharmacology , Cell Proliferation/drug effects , Child , Comet Assay , Cytarabine/pharmacology , Cytotoxicity, Immunologic/drug effects , DNA Damage , DNA Repair/drug effects , Humans , Interleukin-2/metabolism , Interleukin-4/metabolism , Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , T-Lymphocytes/drug effects
...